UNITÉES D'ADMINISTRATION COMPRENNANTE UNE POLYMORPHE 1 DE 2-(2-METHYLAMINO-PYRIMIDIN-4-YL]-1H-INDOLE-5-CARBOXYLIC ACID [(S)-1-CARBAMOYL-2-(PHENYL-PYRIMIDIN-2-YL-AMINO)-ETHYL]-AMIDE
The invention relates to a packaging comprising one or more administration units comprising a sodium salt of (R)-3-[6-amino-pyridin-3-yl]-2-(1-cyclohexyl-1H-imidazol-4-yl)-propionic acid.